Medico Reach

JUNE 16, 2022

The US national healthcare expenditure for 2020 was $4.1 trillion by 2028. Healthcare happens to be the 3rd largest industry in the country, with massive growth happening across the following sectors: Healthcare marketing Healthcare tech Health administration Pharmaceuticals Health insurance. billion Pharma: $169.9

Healthcare 98

Healthcare Healthcare Distribution Insurance 98

PM360

APRIL 7, 2023

No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

pharmaphorum

JANUARY 5, 2023

A new operating model for pharma shifted priorities and forced companies to rethink their organisational strategies. Everything from transitioning to virtual meetings with healthcare providers, to navigating the logistics of supply chain disruptions, has permanently altered pharma operations – many would say for the better.

Pharmaceutical 61

Pharmaceutical Recruitment Training Education 61

Contrarian Sales Techniques

FEBRUARY 10, 2023

According to various market research reports, the global non-invasive medical devices market was valued at approximately USD 45 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of over 6% from 2021 to 2028. This growth is driven by several factors, including: 1.

Healthcare 52

Healthcare Healthcare Manufacturing Medical 52

Clarivate

APRIL 18, 2024

In 2019, UnitedHealth Group CEO David Wichmann indicated a plan to make Optum a $100B business by 2028, including by partnering with health systems for administrative services such as RCM and IT. As of January 2024, CVS reported the number of Aetna members being treated by Oak Street had doubled.

Retail 52

Retail Healthcare Healthcare Physicians 52

pharmaphorum

OCTOBER 10, 2022

As part of efforts to increase uptake of screening programmes, purpose-driven partnerships between the NHS and the pharma industry have emerged as an innovative solution to raise patient awareness. The goal set out by the NHSE Long Term Plan is ambitions: to have three quarters of cancers diagnosed at an early stage by 2028.

Patients 83

Patients Pharma Media Training 83